Trial Profile
Phase III study of lenalidomide for the treatment of non-GCB diffuse large B-cel lymphoma (DLBCL) with a companion diagnostic
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 26 May 2015
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 26 May 2015 New trial record